国际皮肤性病学杂志    2003 29 (6): 379-381   ISSN: 2096-5540  CN: 32-1880/R   抗真菌药物及其作用机制的研究进展 冯华, 吕昭萍 昆明医学院第一附属医院皮肤科, 650031 收稿日期 2002-12-24  修回日期 null  网络版发布日期 null 参考文献  [1] Neely MN,Ghannoum MA.The exciting future of antifungal therapy.Eur J Clin Microbiol Infect Dis,2000,19(12):897-914. [2] Georgopapadakou NH.Antifungals targeted to sphingolipid synthesis:focus on inositol phosphorylceramide synthase.Expert Opin InvestigDrugs,2000,9(8):1787-1796. [3] Hossain MA,Ghannoum MA.New investigational antifungal agents for treating invasive fungal infections.Expert Opin Investig Drugs,2000,9(8):1797-1813. [4] Kappe R.Antifungal activity of the new azole UK-109,496(voriconazole).Mycoses,1999,42(Suppl 2):83-86. [5] Andriole VT.The 1998 Garrod lecture.Current and future antifungal therapy:new targets for antifungal agents.J Antimicrob Chemother,1999,44(2):151-162. [6] Muller FM,Lyman CA,Walsh TJ.Antimicrobial peptides as potential new antifungals.Mycoses,1999,42(Suppl 2):77-82. [7] De Lucca AJ.Antifungal peptides:potential candidates for the treatment of fungal infections.Expert Opin Investig Drugs,2000,9(2):273-299. [8] Dickson RC,Lester RL.Yeast sphingolipids.Biochim Biophys Acta,1999,1426(2):347-357. [9] Mandala SM,Thornton RA,Milligan J,et al.Rustmicin,a potent antifungal agent,inhibits sphingolipid synthesis at inositol phosphoceramide synthase.J Biol Chem,1998,273(24):14942-14949. [10] In Y,Ishida T,Takesako K.Unique molecular conformation of aureobasidin A,a highly amide N-methylated cyclic depsipeptide with potent antifungal activity:X-ray crystal structure and molecular modeling studies.J Pept Res,1999,53(5):492-500. [11] Endo M,Takesako K,Kato I,et al.Fungicidal action of aureobasidin A,a cyclic depsipeptide antifungal antibiotic,against Saccharomycescerevisiae.Antimicrob Agents Chemother,1997,41(3):672-676. [12] De Lucca AJ,Walsh TJ.Antifungal peptides:novel therapeutic compounds against emerging pathogens.Antimicrob Agents Chemother,1999,43(1):1-11. [13] Perlin DS,Seto-Young D,Monk BC.The plasma membrane H(+)ATPase of fungi.A candidate drug target? Ann N Y Acad Sci,1997,834:609-617. [14] Zhang D,Miller MJ.Polyoxins and nikkomycins:progress in synthetic and biological studies.Curr Pharm Des,1999,5(2):73-99. [15] Horsch M,Mayer C,Sennhauser U,et al.Beta-N-acetylhexosaminiduse:a target for the design of antifungal agents.Pharmacol Ther,1997,76(1-3):187-218. [16] Mastrolorenzo A,Scozzafava A,Supuran CT.Antifungal activity of silver and zinc complexes of sulfadrug derivatives incorporating arylsul fonylureido moieties.Eur J Pharm Sci,2000,11(2):99-107. [17] Justice MC,Hsu MJ,Tse B,et al.Elongation factor 2 as a novel tar get for selective inhibition of fungal protein synthesis.J Biol Chem,1998,273(6):3148-3151. [18] Okada H,Kamiya S,Shiina Y,et al.BE-31405,a new antifungal antibiotic produced by Penicillium minioluteum.I.Description of producing organism,fermentation,isolation,physico-chemical and biological properties.J Antibiot(Tokyo),1998,51(12):1081-1086. [19] Lunde CS,Kubo I.Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae.Antimicrob Agents Chemother,2000,44(7):1943-1953. [20] Ueki M,Taniguchi M.The mode of action of UK-2A and UK-3A,novel antifungal antibiotics from Streptomyces sp.517-02.J Antibiot(Tokyo),1997,50(12):1052-1057. [21] Cardenas ME,Cruz MC,Del Poeta M,et al.Antifungal activities of antineoplastic agents:Saccharomyces cerevisiae as a model system to study drug action.Clin Microbiol Rev,1999,12(4):583-611. 通讯作者: